Acyclovir (Systemic) and Insulin Glargine (U-300) Pens
Determining the interaction of Acyclovir (Systemic) and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acyclovir
Brand name: Sitavig, Zovirax
Synonyms: Acyclovir
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acyclovir (Systemic)-Insulin glargine and lixisenatide
- Acyclovir (Systemic)-Insulin glargine and lixisenatide Subcutaneous
- Acyclovir (Systemic)-Insulin glargine, recombinant Subcutaneous
- Acyclovir (Systemic)-Insulin glulisine
- Acyclovir (Systemic)-Insulin Glulisine (Cartridges and Pens)
- Acyclovir (Systemic)-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Acyclovir and Hydrocortisone
- Insulin Glargine (U-300) Pens-Acyclovir and hydrocortisone topical
- Insulin Glargine (U-300) Pens-Acyclovir and hydrocortisone Topical application
- Insulin Glargine (U-300) Pens-Acyclovir Buccal mucosa
- Insulin Glargine (U-300) Pens-Acyclovir Buccal Tablets
- Insulin Glargine (U-300) Pens-Acyclovir Capsules